rHEALTH Technology Issued New Patent For Optical Block

Tuesday, December 5, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

CAMBRIDGE, Ma., Dec. 5, 2017 /PRNewswire-iReach/ -- --rHEALTH LLC announces the issuance of a new patent in the

United States for innovations in optical systems engineering filed by DNA Medicine Institute, DMI. This innovation underscores the portability as well as unique measurement capabilities of the rHEALTH digital diagnostic platform, which represents
the miniaturization and automation of traditional laboratory testing technologies as a point-of-care solution.

The U.S. Patent and Trademark Office has granted the patent number 9,835,542, "Optical Block," for a highly portable and compact, integrated diagnostic system that is designed to measure cells and particles. The unique combination of lasers, detectors, flow channel, lenses, and other electronics within the optical system work to enable precise biomedical measurements. "We are pleased to see this latest patent issuance, which covers one of the core aspects of our diagnostic technology," said Dr. Eugene Y. Chan, Founder and CEO. "The fundamental aspect of this patent enables our technology to make accurate, precise, and quantitative values possible at point-of-care."

This new patent expands the companies' intellectual property portfolio demonstrating DMI and rHEALTH's ongoing commitment to better care through innovation in portable diagnostics and monitoring technologies. 

About rHEALTH

rHEALTH is an innovative digital health solutions company focused on creating integrated technologies that fundamentally change how we care for our health. rHEALTH's innovations consists of the rHEALTH diagnostic platform, which enables diverse laboratory test classes in a single small volume blood sample intended as a point-of-care solution, the SKYE Sensor, a wireless wearable providing comprehensive real-time vitals monitoring and CHAS, a user-friendly mobile application. For more information, visit www.rhealth.com.

About DNA Medicine Institute

DNA Medicine Institute (DMI) is a biomedical incubator focused on advancing patient care, alleviating human suffering, and treating disease through innovation. Its work is supported by NASA, National Institutes of Health, and the Bill & Melinda Gates Foundation. DMI leverages substantial expertise in interdisciplinary science and engineering to solve challenging problems. For more information, visit www.dnamedinstitute.com.

Media Contact: Lillian Li, rHEALTH LLC, (617) 913-7630, [email protected]

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 

SOURCE rHEALTH LLC



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store